🔗 Share this article Social Media Influencers Driving Unofficial Trade for Unlicensed Slimming Drug An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings. Experimental Drug Gaining Popularity Via Social Media Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes. Thriving Trade on Social Networks Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases. Learning About The Experimental Drug Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic. Healthcare Professionals Voice Worries Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin. Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro. Regulatory Position and Enforcement Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations. Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, marketing, and consumer laws, risking fines, legal action or prison. Platform Reaction and Content Removal Based on the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies. Digital Marketplace Activities Research also discovered communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at home. Within minutes of joining one group, a seller posted contact information, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience. Product Details and Costs Inside these groups, messages display dark colored packages with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Service Oversight and Safety Measures A spokesperson for Telegram said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U. A medical professional of an online medical service linked the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said. Her team has already encountered patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.” Producer Position A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.